United Kingdom· GB-APID-39646611000001102
Epimax moisturising cream
A medicinal product containing white soft paraffin + liquid paraffin, registered in United Kingdom by Aspire Pharma Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- White soft paraffin + Liquid paraffin
- Manufacturer
- Aspire Pharma Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin5060209732558
- gtin5060209732541
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
White soft paraffin + liquid paraffin in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/22f7c35a-4b45-4e61-a18c-22424d8b4867 GET /v1/drugs/22f7c35a-4b45-4e61-a18c-22424d8b4867?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "39646611000001102",
"desc": "Epimax moisturising cream (Aspire Pharma Ltd)",
"form": "Cutaneous cream",
"vpid": "14743111000001106",
"source": "dmd",
"vtm_id": "44109811000001104",
"strength": "126 mg",
"substance": "White soft paraffin + Liquid paraffin",
"ingredient": "Liquid paraffin",
"supplier_code": "16666911000001109"
}See everything about white soft paraffin + liquid paraffin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.